Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
$71.32
+0.1%
$71.89
$60.78
$73.59
$1.83B0.78111,740 shs14,790 shs
Banc of California, Inc. stock logo
BANC
Banc of California
$13.93
-0.1%
$14.49
$9.72
$16.08
$2.19B1.152.43 million shs77,081 shs
nVent Electric plc stock logo
NVT
nVent Electric
$75.88
+4.6%
$70.84
$40.19
$78.98
$12.59B1.351.24 million shs104,510 shs
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
$0.82
+7.2%
$0.94
$0.51
$4.31
$7.16M-0.223.67 million shs2,290 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
+0.96%+0.96%-2.63%+2.88%+11.37%
Banc of California, Inc. stock logo
BANC
Banc of California
-1.90%+0.94%-5.30%+5.69%+16.46%
nVent Electric plc stock logo
NVT
nVent Electric
+1.88%-0.91%-1.62%+25.28%+65.45%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
+1.75%+9.46%-30.91%+75,999,900.00%+75,999,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Banc of California, Inc. stock logo
BANC
Banc of California
4.7977 of 5 stars
3.14.01.73.31.73.32.5
nVent Electric plc stock logo
NVT
nVent Electric
4.2322 of 5 stars
3.43.02.50.03.02.52.5
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
0.00
N/AN/AN/A
Banc of California, Inc. stock logo
BANC
Banc of California
2.20
Hold$17.2523.83% Upside
nVent Electric plc stock logo
NVT
nVent Electric
2.86
Moderate Buy$81.607.54% Upside
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/A

Current Analyst Ratings

Latest NVT, AOA, BANC, CUL, and PBM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $15.00
4/10/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $16.00
4/8/2024
nVent Electric plc stock logo
NVT
nVent Electric
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$71.00 ➝ $91.00
4/2/2024
nVent Electric plc stock logo
NVT
nVent Electric
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$74.00 ➝ $85.00
4/1/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$16.00
3/22/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$16.00 ➝ $18.00
3/15/2024
nVent Electric plc stock logo
NVT
nVent Electric
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$69.00 ➝ $77.00
3/11/2024
nVent Electric plc stock logo
NVT
nVent Electric
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$83.00
3/8/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$16.00
2/7/2024
nVent Electric plc stock logo
NVT
nVent Electric
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$65.00 ➝ $72.00
1/30/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$13.00 ➝ $16.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
N/AN/AN/AN/AN/AN/A
Banc of California, Inc. stock logo
BANC
Banc of California
$278.39M7.87$8.76 per share1.59$18.39 per share0.76
nVent Electric plc stock logo
NVT
nVent Electric
$3.26B3.86$4.26 per share17.80$19.03 per share3.99
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
N/AN/A17.61N/AN/AN/AN/AN/A
Banc of California, Inc. stock logo
BANC
Banc of California
-$1.90B-$3.16N/A6.80N/A-44.04%1.14%0.10%N/A
nVent Electric plc stock logo
NVT
nVent Electric
$567.10M$3.3722.5221.371.5317.38%17.53%8.99%5/3/2024 (Confirmed)
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/A0.00N/AN/AN/AN/AN/A

Latest NVT, AOA, BANC, CUL, and PBM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/3/2024N/A
nVent Electric plc stock logo
NVT
nVent Electric
$0.73N/A-$0.73N/AN/AN/A  
4/23/2024Q1 2024
Banc of California, Inc. stock logo
BANC
Banc of California
$0.26$0.19-$0.07$0.21$296.02 million$522.57 million  
2/6/202412/31/2023
nVent Electric plc stock logo
NVT
nVent Electric
$0.75$0.78+$0.03$0.05$866.90 million$861.20 million    
1/25/202412/31/2023
Banc of California, Inc. stock logo
BANC
Banc of California
-$0.28-$4.55-$4.27$3.63$163.11 million$193.06 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
$1.261.77%N/AN/AN/A
Banc of California, Inc. stock logo
BANC
Banc of California
$0.402.87%+18.56%N/A 1 Years
nVent Electric plc stock logo
NVT
nVent Electric
$0.761.00%N/A22.55%1 Years
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/A

Latest NVT, AOA, BANC, CUL, and PBM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/19/2024
nVent Electric plc stock logo
NVT
nVent Electric
Quarterly$0.191.21%4/25/20244/26/20245/10/2024
2/8/2024
Banc of California, Inc. stock logo
BANC
Banc of California
Quarterly$0.103.02%3/14/20243/15/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
N/AN/AN/A
Banc of California, Inc. stock logo
BANC
Banc of California
0.32
0.90
0.89
nVent Electric plc stock logo
NVT
nVent Electric
0.56
1.82
1.22
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Core Aggressive Allocation ETF stock logo
AOA
iShares Core Aggressive Allocation ETF
N/A25.60 millionN/ANot Optionable
Banc of California, Inc. stock logo
BANC
Banc of California
2,304157.27 million152.87 millionOptionable
nVent Electric plc stock logo
NVT
nVent Electric
11,300165.96 million161.81 millionOptionable
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/A8.79 million8.47 millionN/A

NVT, AOA, BANC, CUL, and PBM Headlines

SourceHeadline
Psyence Biomedical (NASDAQ:PBM)  Shares Down 1.8% Psyence Biomedical (NASDAQ:PBM) Shares Down 1.8%
americanbankingnews.com - April 18 at 2:44 AM
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
finance.yahoo.com - April 17 at 12:49 PM
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
globenewswire.com - April 17 at 8:00 AM
Psyence Groups NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin TrialPsyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
globenewswire.com - April 16 at 11:01 AM
Psyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin TrialPsyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial
tmcnet.com - April 8 at 12:13 PM
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin TrialPsyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
globenewswire.com - April 8 at 8:00 AM
Psyence Group Inc.: Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical BusinessPsyence Group Inc.: Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
finanznachrichten.de - March 28 at 6:23 PM
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical BusinessPsyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
globenewswire.com - March 26 at 11:06 AM
Psyence Biomedical Ltd PBMPsyence Biomedical Ltd PBM
morningstar.com - March 24 at 7:23 PM
PBM Psyence Biomedical Ltd.PBM Psyence Biomedical Ltd.
seekingalpha.com - March 22 at 8:02 PM
Psyence Biomedical Ltd (PBM)Psyence Biomedical Ltd (PBM)
uk.investing.com - March 21 at 4:24 PM
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic PsilocybinPsyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
stockhouse.com - March 18 at 7:19 PM
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic PsilocybinPsyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
globenewswire.com - March 18 at 4:05 PM
Psyence Biomedical faces Nasdaq delisting over market valuePsyence Biomedical faces Nasdaq delisting over market value
uk.investing.com - March 17 at 3:36 PM
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held SharesPsyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
globenewswire.com - March 15 at 4:30 PM
Psyence Groups NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb StudyPsyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
globenewswire.com - March 12 at 11:15 AM
Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future MilestonesPsyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones
globenewswire.com - March 12 at 7:00 AM
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In AustraliaPsyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
benzinga.com - March 11 at 7:54 PM
Why Is Psyence Biomedical (PBM) Stock Up 90% Today?Why Is Psyence Biomedical (PBM) Stock Up 90% Today?
investorplace.com - March 8 at 6:17 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iShares Core Aggressive Allocation ETF logo

iShares Core Aggressive Allocation ETF

NYSEARCA:AOA
iShares Aggressive Allocation ETF (the Fund), formerly iShares S&P Aggressive Allocation Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Aggressive Index (the Aggressive Allocation Index). The Aggressive Allocation Index seeks to measure the performance of an asset allocation strategy targeted to an aggressive risk profile. The Fund is designed for investors seeking long-term capital appreciation. The Fund's investment advisor is BlackRock Fund Advisors.
Banc of California logo

Banc of California

NYSE:BANC
Banc of California, Inc. operates as the bank holding company for Banc of California that provides various banking products and services in California. The company offers deposit products, such as checking, savings, money market, demand, and time deposits; certificates of deposit; retirement accounts; and safe deposit boxes. It also provides real estate loans to professional developers and real estate investors for the acquisition, construction, refinancing, renovation, and on-going operation of commercial real estate properties; commercial real estate mortgage, residential real estate mortgage, and real estate construction and land loans; commercial loans and leases, such as equipment finance, other asset-based, venture capital, secured business, warehouse, and other lending services; small business administration loans; and consumer loans comprising personal, auto, and other loans, as well as home equity and revolving lines of credit. In addition, the company offers international banking, multi-state deposit, and asset and investment management services, as well as cash and treasury management services; and online, mobile, remote deposit, and telephone banking services. It serves small and middle-market businesses, venture capital firms, non-profit organizations, business owners, entrepreneurs, professionals, and high-net worth individuals. Banc of California, Inc. was founded in 1941 and is headquartered in Los Angeles, California.
nVent Electric logo

nVent Electric

NYSE:NVT
nVent Electric plc, together with its subsidiaries, designs, manufactures, markets, installs, and services electrical connection and protection solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company operates through three segments: Enclosures, Electrical & Fastening Solutions, and Thermal Management. The Enclosures segment provides solutions to protect electronics and data in mission critical applications, including data solutions. This segment also offers digital and automation solutions, system integrations, and global services. The Electrical & Fastening Solutions segment provides solutions that connect and protect power and data infrastructure. This segment also offers power connections, fastening solutions, cable management solutions, grounding and bonding systems, and tools and test instruments. The Thermal Management segment offers heat management solutions that protect people and assets. This segment includes heat tracing for freeze protection and process temperature maintenance and control; pipe freeze protection, surface deicing, hot water temperature maintenance, floor heating, fire-rated wiring, and leak detection; and heat trace systems, connected controls, remote monitoring, and annual service programs. The company markets its products through electrical distributors, contractors, and original equipment manufacturers under the CADDY, ERICO, GARDNER BENDER, HOFFMAN, ILSCO, RAYCHEM, SCHROFF, and TRACER brand names. Its products are used for various applications, such as industrial, commercial and residential, infrastructure, and energy. nVent Electric plc was founded in 1903 and is based in London, the United Kingdom.
Psyence Biomedical logo

Psyence Biomedical

NASDAQ:PBM
Newcourt Acquisition Corp is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Newcourt Acquisition Corp is based in Oakland, California.